Sabrina Müller

10PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Time-series analysisRespiratory diseasesTraditional Chinese medicine and treatmentsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 30, 2026
Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study.

|Mar 27, 2025
COVID-19 Disease Burden in the Omicron Variant-Dominated Endemic Phase: Insights from the ROUTINE-COV19 Study Using Real-World German Statutory Health Insurance Data.

Sabrina Müller, Andrea Schmetz, Julia K Knaul

|Nov 29, 2024
Repeat cardiovascular-related procedures and real-world treatment in high-risk patients with hypercholesterolemia or mixed dyslipidemia.

Michael Lehrke, Sabrina Müller, Ulf Maywald

|Nov 14, 2024
Chinese translation validation of the adherence barrier questionnaire (intravitreal anti-vascular endothelial growth factor therapy) in Taiwan.

Yi-Chun Chi, Hui-Min Hsieh, Sabrina Müller

|Sep 18, 2024
Adaptation and validation of the Adherence Barriers Questionnaire for HIV Patients on Antiretroviral Therapy (ABQ-HIV) for the Brazilian context.

Míria Dantas Pereira, Sabrina Müeller, Victor Santana Santos

|May 09, 2022
Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds.

Thomas Wilke, Nils Picker, Sabrina Müller

Pageof 2

Frequent Collaborators

2 joint publications

Thomas Wilke

2 joint publications

Barthold Deiters

1 joint publications

Míria Dantas Pereira

1 joint publications

Victor Santana Santos